Safety of darunavir and atazanavir in HIV-infected children in Europe and Thailand

• Main Authors: Heather Bailey, Intira Jeannie Collins, Tristan Childs, Anna Tostevin, Tessa Goetghebuer, Niels Valerius, Christoph Königs, Luisa Galli, Magda Marczynska, Laura Marques, Luminita Ene, Evgeny Voronin, Liubov Okhonskaia, Antoni Noguera-Julian, Pablo Rojo, Jose Tomas Ramos Amador, Lars Naver, Christoph Rudin, Gonzague Jourdain, Pat Tookey, Carlo Giaquinto, Ali Judd
• Format: Journal
• Published: 2018
• Subjects: Medicine; Pharmacology, Toxicology and Pharmaceutics
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84984677356&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/56254
• Institution: Chiang Mai University

©2016 International Medical Press. Background: Surveillance for mid- and long-term antiretroviral therapy (ART) toxicity in children is important for informing treatment guidelines. We assessed the safety of darunavir (DRV) and atazanavir (ATV), commonly used as second-line protease inhibitors follo...